OpenAI has put new subscriptions to its $200 ChatGPT Pro tier on hold, an unusually blunt response to the strain created by demand for GPT-6 Astra. The pause is not framed as a retreat from the product; it is a capacity triage measure, with the company choosing to preserve service for the users already inside.¹

The pressure point is the Pro tier itself. Thibault Sottiaux said those subscriptions “put the most strain on our systems,” and that pausing them was “the smallest step” OpenAI could take while continuing to offer the broadest possible access. He said the company was adding capacity “as fast as we can.”¹

Sam Altman’s response sharpened the trade-off. He acknowledged that restricting access “would suck,” but said OpenAI would prioritize “great service for customers until we can get back on top of things.”Sam Altman (sama)² The message is clear: existing users come before revenue from another wave of $200 subscribers while infrastructure catches up.

Yet OpenAI is not closing every door. In a parallel move, Greg Brockman announced that verified US clinicians can receive free GPT-6 Astra Pro access through ChatGPT for Clinicians.Greg Brockman (gdb)³ That creates a striking contrast: broad new Pro sales are paused, but a defined professional group is being invited in.

The two decisions point to the same calculation. OpenAI is rationing a heavily used model where demand is most expensive, while reserving capacity for a use case it evidently considers strategically important. For prospective Pro customers, the timeline remains open-ended; the company’s only firm promise is that expansion work is underway.¹